Literature DB >> 12398948

Utility of medical and drug history in fracture risk prediction among men and women.

T P van Staa1, H G M Leufkens, C Cooper.   

Abstract

Preventive strategies against osteoporotic fracture depend, in part, on the availability of simple risk prediction tools whereby pharmacological therapy may be targeted to those at greatest risk. The objective of this study was to evaluate the performance of a series of risk factors routinely listed in primary care records for the prediction of future fracture. Information was obtained from the UK General Practice Research Database, which contains the general practitioner medical records of around 6% of the UK population. We performed a case-control study of all 231,778 adult patients with a recorded fracture between 1988 and 1999 and an equal number of controls, individually matched by age, gender, and medical practice to the cases. In addition to a previous history of fracture, 11 items were identified that independently predicted fracture risk (history of anemia, dementia, cerebrovascular disease, and chronic obstructive pulmonary disease; recent use of oral corticosteroids, anticonvulsants, nonsteroidal anti-inflammatory drugs [NSAIDs], antiarrythmics, hypnotics/anxiolytics, antidepressants, and anti-Parkinson drugs). Three or more of these medical risk factors increased the risk of a vertebral fracture 8.1 times (95% confidence interval [CI] 7.0-9.4) and of hip fracture by 4.6 times (95% CI 4.3-5.0), when compared with subjects without these attributes. The optimum screening characteristics of the risk factors for prediction of vertebral fracture revealed a sensitivity 66%, and specificity 89%. These values were 61% and 68%, respectively, for hip fracture. The positive predictive value (PPV) for fracture over a 5 year period improved with the addition of age and previous fracture history to the number of medical risk factors. PPV rose from 8.4% for women aged 65 years without risk factors or fracture history, compared with 26.8% if women had sustained a previous fracture and had three or more risk factors recorded. The data suggest that routinely recorded medical risk factors permit identification of groups of patients with a substantial increase in future risk of fracture. Further investigations, such as bone densitometry, might be conveniently targeted at this group of patients. Copyright 2002 Elsevier Science Inc.

Entities:  

Mesh:

Year:  2002        PMID: 12398948     DOI: 10.1016/s8756-3282(02)00848-7

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  19 in total

Review 1.  Prescribing antiepileptics for the elderly: differences between guideline recommendations and clinical practice.

Authors:  Mary Jo V Pugh; Perry J Foreman; Dan R Berlowitz
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

2.  A FRAX® model for the assessment of fracture probability in Belgium.

Authors:  H Johansson; J A Kanis; E V McCloskey; A Odén; J-P Devogelaer; J-M Kaufman; A Neuprez; M Hiligsmann; O Bruyere; J-Y Reginster
Journal:  Osteoporos Int       Date:  2010-03-30       Impact factor: 4.507

3.  Red and White Blood Cell Counts Are Associated With Bone Marrow Adipose Tissue, Bone Mineral Density, and Bone Microarchitecture in Premenopausal Women.

Authors:  Sai Polineni; Megi Resulaj; Alexander T Faje; Erinne Meenaghan; Miriam A Bredella; Mary Bouxsein; Hang Lee; Ormond A MacDougald; Anne Klibanski; Pouneh K Fazeli
Journal:  J Bone Miner Res       Date:  2020-03-23       Impact factor: 6.741

Review 4.  A review of the effect of anticonvulsant medications on bone mineral density and fracture risk.

Authors:  Richard H Lee; Kenneth W Lyles; Cathleen Colón-Emeric
Journal:  Am J Geriatr Pharmacother       Date:  2010-02

5.  Epidemiology of lower limb fractures in general practice in the United Kingdom.

Authors:  J A Kaye; H Jick
Journal:  Inj Prev       Date:  2004-12       Impact factor: 2.399

6.  FRAX and the assessment of fracture probability in men and women from the UK.

Authors:  J A Kanis; O Johnell; A Oden; H Johansson; E McCloskey
Journal:  Osteoporos Int       Date:  2008-02-22       Impact factor: 4.507

7.  The association of newer anticonvulsant medications and bone mineral density.

Authors:  Richard Lee; Kenneth Lyles; Richard Sloane; Cathleen Colón-Emeric
Journal:  Endocr Pract       Date:  2012-09-14       Impact factor: 3.443

8.  Dementia and hip fractures: development of a pathogenic framework for understanding and studying risk.

Authors:  Susan M Friedman; Isaura B Menzies; Susan V Bukata; Daniel A Mendelson; Stephen L Kates
Journal:  Geriatr Orthop Surg Rehabil       Date:  2010-11

9.  Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphosphonates.

Authors:  F de Vries; A L Cooper; S M Cockle; T-P van Staa; C Cooper
Journal:  Osteoporos Int       Date:  2009-03-31       Impact factor: 4.507

10.  Antipsychotic use and the risk of hip/femur fracture: a population-based case-control study.

Authors:  S Pouwels; T P van Staa; A C G Egberts; H G M Leufkens; C Cooper; F de Vries
Journal:  Osteoporos Int       Date:  2009-01-21       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.